| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428199709039008 |
| P698 | PubMed publication ID | 9156650 |
| P50 | author | Kirk R Schultz | Q37830923 |
| P2093 | author name string | Gilman AL | |
| P2860 | cites work | Endosomal aspartic proteinases are required for invariant-chain processing | Q28612976 |
| Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways | Q36361976 | ||
| The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. | Q36362769 | ||
| Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. | Q36363106 | ||
| Defining rules for the peptide-MHC class II interaction | Q40388545 | ||
| T cells as antigen-presenting cells | Q40392456 | ||
| The expression of self antigenic determinants: implications for tolerance and autoimmunity | Q40399563 | ||
| MHC class II antigen processing: biology of invariant chain | Q40747779 | ||
| Identifying strategies for immune intervention | Q40907476 | ||
| Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain | Q41422715 | ||
| Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments | Q41724706 | ||
| Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis | Q41913749 | ||
| Pharmacologic actions of 4-aminoquinoline compounds | Q41921024 | ||
| Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate | Q41921033 | ||
| Chloroquine treatment of interstitial lung disease in children | Q41934237 | ||
| Amodiaquine and hydroxychloroquine in rheumatoid arthritis | Q41946120 | ||
| The differential aspects of the linear isobole in the study of combined action of agents. | Q52400309 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | hydroxychloroquine | Q421094 |
| chloroquine | Q422438 | ||
| P304 | page(s) | 201-210 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease | |
| P478 | volume | 24 |
| Q94571389 | An Update on Current Therapeutic Drugs Treating COVID-19 |
| Q34604474 | Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit |
| Q33853468 | Antimalarials: unapproved uses or indications |
| Q38291146 | Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action? |
| Q38264772 | Autophagy and haematopoietic stem cell transplantation. |
| Q44340746 | Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides. |
| Q39278084 | Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study |
| Q36382986 | Chronic graft versus host disease of oral mucosa: review of available therapies |
| Q34790917 | Chronic ulcerative stomatitis |
| Q41914846 | Chronic ulcerative stomatitis: clinical, histopathologic, and immunopathologic findings |
| Q36845527 | Chronic ulcerative stomatitis: diagnostic and management challenges--four new cases and review of literature |
| Q41912501 | Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease. |
| Q41938693 | Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts |
| Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
| Q33769719 | Pathophysiology and treatment of graft-versus-host disease |
| Q37041531 | Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin |
| Q44100316 | Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis |
| Q59094234 | Treatment of chronic GVHD |
Search more.